Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

Clinical trial NCT00513669 · COMPLETED

Trial details

NCT number: NCT00513669
Sponsor: Swiss Tropical & Public Health Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Falciparum Malaria

Start date: 2008-01-01
Primary completion: 2009-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.